These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 22499213)

  • 1. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
    Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
    Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
    Nam Y; Kim JH; Seo M; Kim JH; Jin M; Jeon S; Seo JW; Lee WH; Bing SJ; Jee Y; Lee WK; Park DH; Kook H; Suk K
    J Biol Chem; 2014 Jun; 289(24):16773-89. PubMed ID: 24808182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.
    Jeon S; Jha MK; Ock J; Seo J; Jin M; Cho H; Lee WH; Suk K
    J Biol Chem; 2013 Aug; 288(33):24116-27. PubMed ID: 23836894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administration.
    Ip JP; Noçon AL; Hofer MJ; Lim SL; Müller M; Campbell IL
    J Neuroinflammation; 2011 Sep; 8():124. PubMed ID: 21943033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pivotal role played by lipocalin-2 in chronic inflammatory pain.
    Jha MK; Jeon S; Jin M; Ock J; Kim JH; Lee WH; Suk K
    Exp Neurol; 2014 Apr; 254():41-53. PubMed ID: 24440229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic polarization of activated astrocytes: the critical role of lipocalin-2 in the classical inflammatory activation of astrocytes.
    Jang E; Kim JH; Lee S; Kim JH; Seo JW; Jin M; Lee MG; Jang IS; Lee WH; Suk K
    J Immunol; 2013 Nov; 191(10):5204-19. PubMed ID: 24089194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lipocalin-2 in brain injury after intracerebral hemorrhage.
    Ni W; Zheng M; Xi G; Keep RF; Hua Y
    J Cereb Blood Flow Metab; 2015 Sep; 35(9):1454-61. PubMed ID: 25853903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
    Bolton C; Wood EG; Ayoub SS
    Fundam Clin Pharmacol; 2013 Oct; 27(5):535-43. PubMed ID: 22742874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lipocalin-2 in liver regeneration.
    Kienzl-Wagner K; Moschen AR; Geiger S; Bichler A; Aigner F; Brandacher G; Pratschke J; Tilg H
    Liver Int; 2015 Apr; 35(4):1195-202. PubMed ID: 25040147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte lipocalin-2 modestly effects disease severity in a mouse model of multiple sclerosis while reducing mature oligodendrocyte protein and mRNA expression.
    Kalinin S; Feinstein DL
    Neurosci Lett; 2023 Oct; 815():137497. PubMed ID: 37748675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
    Tsutsui S; Schnermann J; Noorbakhsh F; Henry S; Yong VW; Winston BW; Warren K; Power C
    J Neurosci; 2004 Feb; 24(6):1521-9. PubMed ID: 14960625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.
    Borkham-Kamphorst E; van de Leur E; Zimmermann HW; Karlmark KR; Tihaa L; Haas U; Tacke F; Berger T; Mak TW; Weiskirchen R
    Biochim Biophys Acta; 2013 May; 1832(5):660-73. PubMed ID: 23376114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin2 protects against airway inflammation and hyperresponsiveness in a murine model of allergic airway disease.
    Dittrich AM; Krokowski M; Meyer HA; Quarcoo D; Avagyan A; Ahrens B; Kube SM; Witzenrath M; Loddenkemper C; Cowland JB; Hamelmann E
    Clin Exp Allergy; 2010 Nov; 40(11):1689-700. PubMed ID: 20412141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MS14 down-regulates lipocalin2 expression in spinal cord tissue in an animal model of multiple sclerosis in female C57BL/6.
    Ebrahimi-Kalan A; Soleimani Rad J; Kafami L; Mohammadnejad D; Habibi Roudkenar M; Khaki AA; Aliyari Serej Z; Mohammadi Roushandeh A
    Iran Biomed J; 2014; 18(4):196-202. PubMed ID: 25326017
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions.
    Labbus K; Henning M; Borkham-Kamphorst E; Geisler C; Berger T; Mak TW; Knüchel R; Meyer HE; Weiskirchen R; Henkel C
    J Proteomics; 2013 Jan; 78():188-96. PubMed ID: 23219901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
    Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S
    Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
    Moliné-Velázquez V; Ortega MC; Vila del Sol V; Melero-Jerez C; de Castro F; Clemente D
    Neurobiol Dis; 2014 Jul; 67():149-64. PubMed ID: 24709559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.